The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TOI The Oncology Institute

Market Closed 03-13 16:00:00 EDT

2.84

+0.22

+8.40%

盘后2.87

+0.03+1.06%

19:56 EDT

High3.39	Low2.76	Vol9.78M
Open3.14	D1 Closing2.62	Amplitude24.05%
Mkt Cap279.40M	Tradable Cap234.13M	Total Shares98.38M
T/O30.31M	T/O Rate11.86%	Tradable Shares82.44M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TOI","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":2.84,"timestamp":1773432000000,"preClose":2.62,"halted":0,"volume":9779395,"hourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.84,"latestTime":"19:56 EDT","volume":47858,"amount":137081.6038,"timestamp":1773446196058,"change":0.03,"changeRate":0.010563,"amplitude":0.028169},"delay":0,"changeRate":0.08396946564885487,"floatShares":82439500,"shares":98381340,"eps":-0.638641,"marketStatus":"Market Closed","change":0.22,"latestTime":"03-13 16:00:00 EDT","open":3.14,"high":3.39,"low":2.76,"amount":30313216.107927002,"amplitude":0.240458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.638641,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.62,"preHourTrading":{"tag":"盘前","latestPrice":3.17,"preClose":2.62,"latestTime":"09:29 EDT","volume":443826,"amount":1372786.661124,"timestamp":1773408599058,"change":0.55,"changeRate":0.209924,"amplitude":0.187023},"postHourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.84,"latestTime":"19:56 EDT","volume":47858,"amount":137081.6038,"timestamp":1773446196058,"change":0.03,"changeRate":0.010563,"amplitude":0.028169},"volumeRatio":6.118152,"optionData":{"bulkOrders":[{"symbol":"TOI","call":true,"expireDate":1787284800000,"strike":"4.0","timestamp":1773419253274,"price":0.4,"volume":1200,"amount":48000,"type":"-"}]},"impliedVol":1.0101,"impliedVolPercentile":0.5093},"requestUrl":"/m/hq/s/TOI","defaultTab":"news","newsList":[{"id":"2619818146","title":"Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=2619818146","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619818146?lang=en_us&edition=fundamental","pubTime":"2026-03-14 06:24","pubTimestamp":1773440657,"startTime":"0","endTime":"0","summary":"Oncology Institute (TOI) closed out FY 2025 with Q4 revenue of US$142.0 million and a basic EPS loss of US$0.07, while trailing twelve month figures show revenue of US$502.7 million and a net loss of US$60.6 million. The company has seen quarterly revenue move from US$100.3 million in Q4 2024 to US$142.0 million in Q4 2025, with basic EPS losses ranging from US$0.21 in Q1 2025 to US$0.07 in Q4, presenting a picture in which top line scale is increasing while margins remain clearly...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/oncology-institute-toi-q4-loss-per-share-improvement-tests-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/oncology-institute-toi-q4-loss-per-share-improvement-tests-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2619194187","title":"B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194187?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:59","pubTimestamp":1773403191,"startTime":"0","endTime":"0","summary":"B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2619219165","title":"Oncology Institute Price Target Maintained With a $5.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2619219165","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619219165?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:31","pubTimestamp":1773401460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2026 07:31 ET (11:31 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2619193990","title":"Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2619193990","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619193990?lang=en_us&edition=fundamental","pubTime":"2026-03-13 17:41","pubTimestamp":1773394860,"startTime":"0","endTime":"0","summary":"The Oncology Institute (TOI) stock rose in pre-market trading after reporting better-than-expected financial results. Other gainers include ISPC, PAYP, and EONR.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/03/51234968/why-oncology-institute-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/03/51234968/why-oncology-institute-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2619155775","title":"Oncology Institute Q4 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2619155775","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619155775?lang=en_us&edition=fundamental","pubTime":"2026-03-13 05:58","pubTimestamp":1773352728,"startTime":"0","endTime":"0","summary":"Oncology Institute  reported a Q4 loss late Thursday of $0.06 per diluted share, narrowing from the loss of $0.14 a year earlier.Four analysts polled by FactSet expected a loss of $0.09.Revenue for the three months ended Dec. 31 rose to $142 million from $100.3 million a year earlier.Four analysts expected $139.8 million.The company expects full-year 2026 revenue of $630 million to $650 million.Four analysts project $636.2 million.Oncology Institute shares rose 13% in after-hours trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2618942069","title":"Tempus AI study finds 12% of community oncology patients gain actionable results from advanced genomic profiling features","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942069?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:31","pubTimestamp":1773232260,"startTime":"0","endTime":"0","summary":"Tempus reported a clinical study published in JCO Precision Oncology evaluating advanced features of comprehensive genomic profiling in community oncology settings. The study was conducted with The Oncology Institute and assessed tumor-normal matched sequencing, RNA sequencing, and liquid biopsy reflex testing. Across pilot and expanded cohorts, 12% of patients had potentially actionable findings tied to an approved therapy that were identified only through these advanced profiling features. The announcement did not state that results were previously presented or scheduled for future presentation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL2bgzhY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4613","LU1861559042.SGD","BK4185","TEM","TOI","TEMT","LU1861558580.USD","BK4121"],"gpt_icon":1},{"id":"2618969325","title":"Oncology Institute Inc  expected to post a loss of 9 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618969325","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618969325?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:17","pubTimestamp":1773173825,"startTime":"0","endTime":"0","summary":"Oncology Institute Inc  expected to post a loss of9cents a share - Earnings Preview Oncology Institute Inc TOI.OQ TOI.O is expected to  show a rise in quarterly revenue when it reports  results on Mar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nL8N3ZY2IW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2618647470","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Incyte (INCY) and Oncology Institute (TOI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618647470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618647470?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:40","pubTimestamp":1773052830,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report), Incyte...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-incyte-incy-and-oncology-institute-toi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-roche-holding-ag-otherrhhvf-incyte-incy-and-oncology-institute-toi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4210","XLV","AG","TOI","BK4581","LABU","BK4137","BK4139","BK4550","INCY","BK4585","LU0128526141.USD","BK4532","LU0029874061.USD","BK4588","BK4185","XBI","HCSG"],"gpt_icon":0},{"id":"2618429406","title":"Oncology Institute Price Target Maintained With a $7.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2618429406","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618429406?lang=en_us&edition=fundamental","pubTime":"2026-03-09 18:05","pubTimestamp":1773050700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 06:05 ET (10:05 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2614044659","title":"The Oncology Institute Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2614044659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614044659?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:03","pubTimestamp":1772111005,"startTime":"0","endTime":"0","summary":"The Oncology Institute Inc. published an update to their financial calendar               The Oncology Institute Inc. will release its fourth quarter and full year 2025 financial results on Thursday, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL9mBvg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","BK4112","BK4588","LU2210149790.SGD","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","TOI","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014005.SGD","BK4185","SG9999014039.USD","NDAQ","BK4585"],"gpt_icon":0},{"id":"2614082160","title":"The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082160?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:00","pubTimestamp":1772024457,"startTime":"0","endTime":"0","summary":"The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March               The Oncology Institute Inc. will have members of its executive leadership team participate in m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL6CrfSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BKPKM429.USD","LU0314104364.USD","BK4112","BK4185","TOI","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","BK4588","BK4585","SG9999014021.USD","SG9999014039.USD","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2613782183","title":"Oncology Institute appoints Kim Tzoumakas to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613782183","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613782183?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:12","pubTimestamp":1771852351,"startTime":"0","endTime":"0","summary":"The Oncology Institute (TOI) announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas is CE...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oncology-institute-appoints-kim-tzoumakas-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oncology-institute-appoints-kim-tzoumakas-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2613784712","title":"The Oncology Institute Names Kim Tzoumakas to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613784712","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613784712?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851645,"startTime":"0","endTime":"0","summary":"The Oncology Institute Inc. appointed Kim Tzoumakas to its Board of Directors, effective Feb. 23, 2026. Tzoumakas is CEO of VytlOne National Pharmacy Services and previously served as CEO of 21st Century Oncology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLbykB9t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","IE00BGHQF748.EUR","SG9999014021.USD","IE00BKPKM429.USD","BK4588","SG9999014013.SGD","TOI","LU0314104364.USD","BK4112","LU2210150020.SGD","SG9999014005.SGD","LU2210149790.SGD","LU2095319765.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","NDAQ"],"gpt_icon":0},{"id":"2613784204","title":"the Oncology Institute Appoints Kim Tzoumakas to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613784204","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613784204?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851608,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA1FRC7X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOIIW","BK4185","TOI"],"gpt_icon":0},{"id":"2603299065","title":"The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper","url":"https://stock-news.laohu8.com/highlight/detail?id=2603299065","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603299065?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:57","pubTimestamp":1768255061,"startTime":"0","endTime":"0","summary":"The Oncology Institute Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing names Mark Stolper as the beneficial owner in his capacity as Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL79gYB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOI","BK4185"],"gpt_icon":0},{"id":"2602517008","title":"The Oncology Institute Targets 20% Annual Revenue Growth Through 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517008","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517008?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222854,"startTime":"0","endTime":"0","summary":"The Oncology Institute Inc. has reaffirmed its 2025 financial guidance and provided a preliminary outlook for 2026. The company, one of the largest value-based oncology groups in the United States, continues to use Adjusted EBITDA as a key metric to assess its operational and financial performance. No significant variations in business performance for the period were disclosed in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL3yFkCx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4112","NDAQ","BK4185","BK4588","IE00B3QW5Z07.USD","TOI","IE00BKPKM429.USD","BK4585","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","SG9999014039.USD","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2602517726","title":"the Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517726?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA1ZXKY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOIIW","BK4185","TOI"],"gpt_icon":0},{"id":"2602510870","title":"Oncology Institute Inc: Looking Beyond 2026, Co Is Well Positioned for Continued Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510870?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222807,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA1ZXKY1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOI","TOIIW","BK4185"],"gpt_icon":0},{"id":"2602951031","title":"Press Release: The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2602951031","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602951031?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:00","pubTimestamp":1768222800,"startTime":"0","endTime":"0","summary":"CERRITOS, Calif., Jan. 12, 2026  -- The Oncology Institute, Inc.  , one of the largest value-based oncology groups in the United States, today reaffirmed 2025 guidance and provided its preliminary 2026 outlook.For 2026, TOI anticipates that total revenue will be in the range of $630 million to $650 million, reflecting 28% growth from the midpoint of 2025 and 2026 guidance ranges, and including approximately $150 million of Capitation revenue in 2026. This expected top-line increase reflects continued expansion of delegated contracts in Florida, the annualized impact of strong volumes in the Dispensary segment during the second half of 2025, and broader organic growth and new contract wins across the platform. While these drivers are expected to contribute meaningfully to revenue in 2026, the Company anticipates profitability from newly onboarded delegated contracts to build progressively over the course of the year, with more fully realized economics in 2027.As TOI continues to scale, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","TOI"],"gpt_icon":0},{"id":"2602855075","title":"Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602855075","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602855075?lang=en_us&edition=fundamental","pubTime":"2026-01-10 10:22","pubTimestamp":1768011724,"startTime":"0","endTime":"0","summary":"The Oncology Institute, Inc. recently promoted Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer, and added RadNet CFO Mark Stolper to its Board of Directors, bringing deeper technology, cybersecurity, people operations, and healthcare finance expertise into its leadership ranks.\nThese leadership moves underscore the company’s focus on AI-enabled care, data privacy, and organizational strength as it refines its value-based cancer care model.\nNext, we’ll...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/is-oncology-institutes-toi-new-techheavy-leadership-team-qui","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-toi/oncology-institute/news/is-oncology-institutes-toi-new-techheavy-leadership-team-qui","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AI","TOI","BK4023","BK4551","BK4120","BK4587","TISI","BK4588","BK4585","BK4528","BK4543","BK4185"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theoncologyinstitute.com","stockEarnings":[{"period":"1week","weight":0.0216},{"period":"1month","weight":0.084},{"period":"3month","weight":-0.2487},{"period":"6month","weight":-0.0689},{"period":"1year","weight":3.3699},{"period":"ytd","weight":-0.2022}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.260474},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.061864},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.019592},{"month":4,"riseRate":0.6,"avgChangeRate":0.143821},{"month":5,"riseRate":0.4,"avgChangeRate":-0.057716},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094312},{"month":7,"riseRate":0.833333,"avgChangeRate":0.340043},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.040327},{"month":9,"riseRate":0.5,"avgChangeRate":-0.018468},{"month":10,"riseRate":0.5,"avgChangeRate":0.091691},{"month":11,"riseRate":0,"avgChangeRate":-0.319754},{"month":12,"riseRate":1,"avgChangeRate":0.32933}],"exchange":"NASDAQ","name":"The Oncology Institute","nameEN":"The Oncology Institute"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"The Oncology Institute,TOI,The Oncology Institute股票,The Oncology Institute股票老虎,The Oncology Institute股票老虎国际,The Oncology Institute行情,The Oncology Institute股票行情,The Oncology Institute股价,The Oncology Institute股市,The Oncology Institute股票价格,The Oncology Institute股票交易,The Oncology Institute股票购买,The Oncology Institute股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"The Oncology Institute(TOI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest The Oncology Institute(TOI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}